REFILE-TABLE-Sawai Pharmaceutical-Q1 group results
(Adds company forecast. Accounting policy for forecast is IFRS) Aug 14 (Reuters)- Sawai Pharmaceutical Co Ltd CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) 3 months ended 3 months ended Year to Jun 30, 2017 Jun 30, 2016 Mar 31, 2018 LATEST YEAR-AGO LATEST RESULTS RESULTS FORECAST Sales 33.65 32.95 142.00 (+2.1 pct) (+12.1 pct) Operating 5.38 5.89 24.20 (-8.7 pct) (-7.3 pct) Recurring 6.11 5.91 23.80 (+3.3 pct) (-5.6 pct) Net 4.66 4.36 18.20 (+6.9 pct) (-14.4 pct) EPS 126.31 yen 118.19 yen 493.65 yen EPS Diluted 126.23 yen 118.13 yen Ann Div 130.00 yen 130.00 yen -Q2 div 65.00 yen 65.00 yen -Q4 div 65.00 yen 65.00 yen NOTE - Sawai Pharmaceutical Co Ltd. To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4555.T